Low prevalence of B-type natriuretic peptide levels <100 pg/mL in patients with heart failure at hospital discharge

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 1012.e1-1012.e5

  Hogenhuis, Jochem ^a   Voors, Adriaan A ^a   Jaarsma, Tiny ^a   Hillege, Hans L ^a   Hoes, Arno W ^b   van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; HEART; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTOLE;

AGED; AGED, 80 AND OVER; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; SYSTOLE;

EID: 33646103891     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.02.025     Document Type: Article

References (21)

1. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 26 (2005) 1115-1140
2. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
4. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
5. Caldwell M.A., Howie J.N., and Dracup K. BNP as discharge criteria for heart failure. J Card Fail 9 (2003) 416-422
6. Tang W.H., Girod J.P., Lee M.J., et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108 (2003) 2964-2966
7. Jaarsma T., van der Wal M.H.L., Hogenhuis J., et al. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail 6 (2004) 227-233
8. Tjeerdsma G., de Boer R.A., Boomsma F., et al. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol 86 (2002) 143-149
9. Wieczorek S.J., Wu A.H., Christenson R., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144 (2002) 834-839
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl 1 (2002) S46-S75
11. Morrison L.K., Harrision A., Krishnaswamy P., et al. Utility of a rapid B-type natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
12. Doust J.A., Glasziou P.P., Pietrzak E., et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164 (2004) 1978-1984
13. Mukoyama M., Nakao K., Saito Y., et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323 (1990) 757-758
14. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 (2001) 21-29
15. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19
16. Wang T.J., Larson M.G., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
17. Krauser D.G., Lloyd-Jones D.M., Chae C.U., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149 (2005) 744-750
18. Sarzani R., Dessi-Fulgheri P., Paci V.M., et al. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 19 (1996) 581-585
19. Morabito D., Valloton M.B., and Lang U. Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats. J Investig Med 49 (2001) 310-318
20. Licata G., Volpe M., Scaglione R., et al. Salt-regulating hormones in young normotensive obese subjects. Effect of saline load. Hypertension 23 Suppl (1994) I20-I24
21. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641